Fujian Cosunter Jintang Pharmaceutical Co., Ltd. announced that it will receive CNY 30 million in an equity round of funding on July 27, 2022. The transaction will include participation from returning investor, Fujian Cosunter Pharmaceutical Co., Ltd. to retain its 100% stake in the company. The registered capital of the company will increase from CNY 140 million to CNY 170 million post closing of the transaction.

The transaction has been approved at the fourteenth meeting of the fourth board of directors and the thirteenth meeting of the fourth board of supervisors of the investor.